BioNexus pushes Malaysia–China biotech co-development
BioNexus Gene Lab (Nasdaq:BGLC) highlighted its role at the 2026 China–Malaysia Economic Cooperation Outlook Forum, advocating deeper Malaysia–China biotechnology cooperation beyond trade. CEO Sam Tan outlined a Malaysia-based ASEAN execution hub for precision diagnostics, liquid biopsy, MRD monitoring, AI-integrated healthcare, and public-market-supported regional commercialization platforms. Loading… Loading translation… AI-generated…